Salisbury Foundation Trust

FOI_8778

Internal Reference Number: FOI_8778

Date Request Received: 17/07/2025 00:00:00

Date Request Replied To: 22/07/2025 00:00:00

This response was sent via: By Email

Request Summary: Oncology

Request Category: Researcher

 
Question Number 1:
I have a freedom of information request regarding the treatment of certain types of cancer. Could you please answer the following questions.

How many early-stage (non-metastatic or Stages 1-3) non-small cell lung cancer (NSCLC) patients were treated in the past 3 months with:

• Atezolizumab (Tecentriq)

• Durvalumab (Imfinzi)

• Nivolumab (Opdivo)

• Pembrolizumab (Keytruda)

• Chemotherapy

• Radiotherapy

• Chemotherapy AND Radiotherapy

• Osimertinib
 
Answer To Question 1:
The Trust do not do radiotherapy at SFT so therefore cannot provide that information and do not know if the chemo is in combination with radiotherapy.
 
Question Number 2:
How many patients has your trust treated in the last 3 months with Pembrolizumab for stage II Melanoma?
 
Answer To Question 2:
Zero
 
Question Number 3:
How many patients has your Trust treated in total in the past 3 months for

• Stage 2 Non-Small Cell Lung Cancer

• Stage 3 Non-Small Cell Lung Cancer
 
Answer To Question 3:
• Stage 2 Non-Small Cell Lung Cancer = 0

• Stage 3 Non-Small Cell Lung Cancer = <= 5
 
Question Number 4:
How many Stage 2-3 non-small cell lung cancer (NSCLC) patients were treated in the past 3 months with:

• Atezolizumab

• Pembrolizumab monotherapy

• Pembrolizumab with chemotherapy

• Nivolumab

• Osimertinib

• Durvalumab

• Chemotherapy

• Radiotherapy

• Chemotherapy and Radiotherapy
 
Answer To Question 4:
Zero
 
Question Number 5:
How many Stage 2-3 non-small cell lung cancer (NSCLC) patients were treated in the past 3 months following surgery with:

• Chemotherapy

• Radiotherapy

• Chemotherapy + Radiotherapy



 
Answer To Question 5:
Zero
 
Question Number 6:
How many Stage 2-3 resectable non-small cell lung cancer (NSCLC) patients were treated in the past 3 months with:

• Durvalumab
 
Answer To Question 6:
Zero
 
To return to the list of all the FOI requests please click here

Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.

Person Centred & Safe

Professional

Responsive

Friendly

Progressive

Salisbury NHS Foundation Trust, Salisbury District Hospital, Odstock Road, Salisbury, Wiltshire, SP2 8BJ
T: 01722 336262 E: sft.pals@nhs.net
© 2025 Salisbury NHS Foundation Trust
Trust Values